Goyal R, Singhal M, Jialal I. Type 2 Diabetes. 2023 [cited 2024 Nov 4]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/
Majid H, Kohli S, Islam SU, Nidhi N. The role of branched chain aminotransferase in the interrelated pathways of type 2 diabetes mellitus and Alzheimer’s disease. J Diabetes Metab Disord. 2025;24:1–15. https://doi.org/10.1007/s40200-025-01597-6.
Diabetes Facts and Figures|International Diabetes Federation. [cited 2024 Nov 10]. Available from: https://idf.org/about-diabetes/diabetes-facts-figures/
Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, et al. Alzheimer’s disease and type 2 diabetes mellitus: pathophysiologic and pharmacotherapeutics links. World J Diabetes. 2021;12:745.
Article PubMed PubMed Central Google Scholar
Chauhan A, Dubey S, Jain S. Association between type 2 diabetes mellitus and alzheimer’s disease: common molecular mechanism and therapeutic targets. Cell Biochem Funct. 2024;42:e4111. https://doi.org/10.1002/cbf.4111.
Article CAS PubMed Google Scholar
Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho das MG, Caramelli P, Braga Gomes K. Alzheimer’s disease and type 2 diabetes mellitus: a systematic review of proteomic studies. J Neurochem. 2021;156:753–76. https://doi.org/10.1111/jnc.15166.
Article CAS PubMed Google Scholar
Nodirahon A, Majid H, Waghdhare S, Vohora D, Nidhi N. The effect of sodium glucose Co-transport 2 inhibitors on cognitive impairment and depression in type 2 diabetes mellitus patients. Clin Epidemiol Glob Health. 2024;26:101555.
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88:1322–35.
Article PubMed PubMed Central Google Scholar
Lee J. Mild cognitive impairment in relation to Alzheimer’s disease: an investigation of principles, classifications, ethics, and problems. Neuroethics. 2023;16:16.
Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12:35.
Article CAS PubMed PubMed Central Google Scholar
What is Alzheimer’s Disease? Symptoms & Causes | alz.org. [cited 2024 Nov 4]. Available from: https://www.alz.org/alzheimers-dementia/what-is-alzheimers
What Happens to the Brain in Alzheimer’s Disease? | National Institute on Aging. [cited 2024 Nov 4]. Available from: https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease
Crawford L, Loprinzi PD. Alzheimer’s Disease: Memory Interference and the Role of Exercise. Alzheimer’s Disease. 2019 [cited 2024 Nov 4];193–204. Available from: https://www.ncbi.nlm.nih.gov/books/NBK552139/
2023 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2023;19:1598–695. https://doi.org/10.1002/alz.13016
2020 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2020;16:391–460. https://doi.org/10.1002/alz.12068
Bondi MW, Edmonds EC, Salmon DP. Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc. 2017;23:818.
Article PubMed PubMed Central Google Scholar
Aramadaka S, Mannam R, Narayanan RS, Bansal A, Yanamaladoddi VR, Sarvepalli SS, et al. Neuroimaging in Alzheimer’s disease for early diagnosis: a comprehensive review. Cureus. 2023;15:38544.
Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, et al. Alzheimer’s retinopathy: seeing disease in the eyes. Front Neurosci. 2020;14: 566483.
Kueper JK, Speechley M, Montero-Odasso M. The Alzheimer’s disease Assessment Scale-Cognitive Subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review. J Alzheimer’s Dis. 2018;63:423.
Cognitive Assessment Tools | Alzheimer’s Association. [cited 2024 Nov 6]. Available from: https://www.alz.org/professionals/health-systems-medical-professionals/clinical-resources/cognitive-assessment-tools
Palsetia D, Rao G, Tiwari S, Lodha P, De Sousa A. The clock drawing test versus mini-mental status examination as a screening tool for dementia: a clinical comparison. Indian J Psychol Med. 2018;40:1.
Article PubMed PubMed Central Google Scholar
Rakusa M, Jensterle J, Mlakar J. Clock drawing test: a simple scoring system for the accurate screening of cognitive impairment in patients with mild cognitive impairment and dementia. Dement Geriatr Cogn Disord. 2018;45:326–34. https://doi.org/10.1159/000490381.
Seitz DP, Chan CCH, Newton HT, Gill SS, Herrmann N, Smailagic N, et al. Mini-Cog for the detection of dementia within a primary care setting. Cochrane Database Syst Rev. 2021;2021:CD011415.
Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, et al. Imaging methods applicable in the diagnostics of Alzheimer’s disease, considering the involvement of insulin resistance. Int J Mol Sci. 2023;24:3325.
Article PubMed PubMed Central Google Scholar
Wu T, Lin D, Cheng Y, Jiang S, Riaz MW, Fu N, et al. Amyloid cascade hypothesis for the treatment of alzheimer’s disease: progress and challenges. Aging Dis. 2022;13:1745.
Article PubMed PubMed Central Google Scholar
Langerscheidt F, Wied T, Al Kabbani MA, van Eimeren T, Wunderlich G, Zempel H. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies. J Neurol. 2024;271:2992–3018.
Article PubMed PubMed Central Google Scholar
Nadeem M, Majid H, Ansari MD, Ahmad FJ, Parvez S, Akhtar M, et al. Development and optimization of piracetam and shatavarin IV-loaded nanoemulsion for alzheimer’s disease therapy: in silico and experimental analysis. ACS Omega. 2025. https://doi.org/10.1021/acsomega.4c09072.
Article PubMed PubMed Central Google Scholar
Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Peña V. GSK3β and Tau protein in Alzheimer’s disease and epilepsy. Front Cell Neurosci. 2020;14:19.
Article CAS PubMed PubMed Central Google Scholar
Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78: 103970.
Article CAS PubMed PubMed Central Google Scholar
Jewett BE, Thapa B. Physiology, NMDA Receptor. StatPearls. 2022 [cited 2024 Nov 10]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK519495/
Glutamate: What It Is & Function. [cited 2024 Nov 10]. Available from: https://my.clevelandclinic.org/health/articles/22839-glutamate
Wang R, Reddy PH. Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimers Dis. 2017;57:1041.
Article CAS PubMed PubMed Central Google Scholar
Xie J, Van Hoecke L, Vandenbroucke RE. The impact of systemic inflammation on Alzheimer’s disease pathology. Front Immunol. 2022;12:796867.
Article PubMed PubMed Central Google Scholar
Wu K-M, Zhang Y-R, Huang Y-Y, Dong Q, Tan L, Yu J-T. The role of the immune system in Alzheimer’s disease. Ageing Res Rev. 2021;70: 101409.
Article CAS PubMed Google Scholar
Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease. Front Neurosci. 2020;14.
Sędzikowska A, Szablewski L. Insulin and insulin resistance in Alzheimer’s disease. Int J Mol Sci. 2021;22:9987.
Article PubMed PubMed Central Google Scholar
Eisenmenger LB, Peret A, Famakin BM, Spahic A, Roberts GS, Bockholt JH, et al. Vascular contributions to Alzheimer’s disease. Transl Res. 2023;254:41–53.
Article CAS PubMed Google Scholar
Sehrawat A, Mishra J, Mastana SS, Navik U, Bhatti GK, Reddy PH, et al. Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications. Biochim Biophys Acta (BBA) Mol Basis Dis. 2023;186:166666.
Zhao X, Bie LY, Pang DR, Li X, Yang LF, Chen DD, et al. The role of autophagy in the treatment of type II diabetes and its complications: a review. Front Endocrinol (Lausanne). 2023;14:1228045.
Article PubMed PubMed Central Google Scholar
Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z. AMPK/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury. Front Physiol. 2020;11: 619730.
Comments (0)